Skin Inflammation in Human Health and Disease, 2021

摘要 该提案寻求对2021年题为《人类皮肤炎症》的国际会议的支持 《2021年健康与疾病》将于2021年7月7日至9日在马萨诸塞州波士顿举行。这样做的目的是 会议将分享基础和转化性人类皮肤病研究的最新进展，以 宣传可用于翻译人类研究的新分析工具和技术，以得出新的 人类皮肤病研究领域的研究人员，并支持年轻的研究人员和 对这一领域感兴趣的代表不足的少数族裔。本次会议将得到赞助，并将部分 由哈佛医学院NIAMS P30资助的人类皮肤病资源中心支持， 该中心寻求加快人类皮肤病的翻译研究。我们招募了一支世界级的团队 公认的人类皮肤免疫学专家担任演讲者，其中52%是女性。摘要将会是 简短的口头或海报演示将选择征集和演示文稿.我们将支持新的和 通过与选定的讲师教职员工举行导师午餐会，代表不足的调查人员，提供五个完整 支付旅行补助金，并免除研究生和住院医生的注册费。这次会议是独一无二的 其重点是人类转化性皮肤病研究，即对人类细胞和 直接目标是影响病人护理的组织。我们预计将有100-200名国际参与者， 包括医生、科学家、内科科学家、其他保健提供者以及研究生和 皮肤科和免疫学的住院医生。这次会议将通过哈佛大学获得CME认证。 通过将世界人类翻译研究专家聚集在一起，我们希望将医生带入 翻译研究，鼓励研究人员在他们的工作中使用人类细胞和组织，并招募 对人类皮肤病研究的新的和代表性不足的调查人员。

Abstract This proposal seeks support for the 2021 International Conference entitled “Skin Inflammation in Human Health and Disease, 2021” to be held July 7-9th 2021, in Boston, Massachusetts. The objectives of this conference are to share the latest developments in basic and translational human skin disease research, to publicize new analytic tools and techniques that can be used for translational human research, to draw new investigators into the field of human skin disease research and to support young investigators and underrepresented minorities who are interested in this field. This conference will be sponsored and partially supported by the NIAMS P30 funded Human Skin Disease Resource Center at Harvard Medical School, a Center that seeks to accelerate translational human skin disease research. We have recruited a team of world recognized experts in human skin immunology as speakers, 52% of whom are women. Abstracts will be solicited and presentations will be selected for short oral or poster presentations. We will support new and underrepresented investigators by holding a mentorship lunch with chosen speaker faculty, offering five full cost travel grants, and waived registration fees for graduate students and residents. This conference is unique in its focus on human translational skin disease research, namely on research carried out on human cells and tissues with the direct goal of impacting patient care. We anticipate between 100-200 international participants, including physicians, scientists, physician scientists, other health care providers, and graduate students and residents in dermatology and immunology. The conference will be CME accredited through Harvard University. By bringing together the world experts in human translational research, we hope to bring physicians into translational research, to encourage researchers to use human cells and tissues in their work, and to recruit new and underrepresented investigators into human skin disease research.